Well, the (somehow almost worthless) drug strikes again.  In a world enamored with Covid, Apabetalone appears to be efficacious both against Covid spike protein (making Apabetalone effective against any conceivable variant) and also with respect to inflammation (that impact can't possibly be limited to Covid patients).

And here we sit. Apparently doing free R&D for some lucky creditor.

Can't make this stuff up.